表紙
市場調査レポート

遺伝子検査の世界市場:2015年〜2019年

Global Genetic Testing Market 2015-2019

発行 TechNavio (Infiniti Research Ltd.) 商品コード 276812
出版日 ページ情報 英文 82 Pages
即納可能
価格
本日の銀行送金レート: 1USD=106.02円で換算しております。
Back to Top
遺伝子検査の世界市場:2015年〜2019年 Global Genetic Testing Market 2015-2019
出版日: 2015年07月22日 ページ情報: 英文 82 Pages
概要

世界の遺伝子検査市場は、遺伝子疾患の増加などの影響により、2014年から2019年の間、9.65%のCAGRで拡大する見込みです。

当レポートでは、世界における遺伝子検査市場の現況とその将来予測、市場の成長因子と課題、主な動向、主要ベンダーの分析などを提供しています。

第1章 エグゼクティブサマリー

第2章 略語リスト

第3章 調査範囲

  • 市場概要
  • 主な製品

第4章 市場調査手法

  • 市場調査プロセス
  • 調査手法

第5章 イントロダクション

第6章 市場情勢

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第7章 用途別の市場分類

第8章 遺伝子検査における規制

第9章 DTC遺伝子検査

  • DTC遺伝子検査の利点と欠点
  • DTC遺伝子検査における規制

第10章 地理区分

  • 南北アメリカ
    • 市場規模と予測
  • 欧州・中東・アフリカ地域
    • 市場規模と予測
  • アジア太平洋地域
    • 市場規模と予測

第11章 購入基準

第12章 市場成長因子

第13章 成長因子とその影響

第14章 市場の課題

第15章 成長因子と課題の影響

第16章 市場動向

第17章 動向とその影響

第18章 ベンダー情勢

  • 競合シナリオ
    • M&A
  • 市場シェア分析
  • その他の有力ベンダー

第19章 主要ベンダーの分析

  • Abbott Laboratories
  • Bio-Rad Laboratories
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

第20章 関連レポート

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: IRTNTR6482

About Genetic Testing

Genetic testing is the most profitable and rapidly expanding segment of molecular diagnostics. It is the array of techniques used for the analysis of DNA, RNA, and protein. It is used as a medical tool to determine the genetic defects associated with a particular disease. Genetic testing is also used in non-clinical applications such as paternity testing and forensics. In clinical applications, the primary focus of genetic testing is to identify the genetic reason for the cause of a disease, confirm a suspected diagnosis, prediction of future disease, to identify when an individual may pass his/her hereditary information to kids, and to predict treatment response in a patient. Genetic testing is also used to screen new-born babies, foetuses, or embryos used in vitro fertilization for genetic defects. The genetic testing market is categorized based on its applications into pharmacogenomics testing, predictive testing, prenatal and neonatal testing.

Technavio's analysts forecast the global genetic testing market to grow at a CAGR of 9.65% over the period 2014-2019.

Covered in this Report

The report includes the present scenario and the growth prospects of the global genetic testing market for the period 2015-2019. To calculate the market size, we consider the revenue generated from the applications of the genetic testing:

Technavio's report, Global Genetic Testing Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Regions

  • Americas
  • EMEA
  • APAC

Key Vendors

  • Abbott Laboratories
  • BioRad Laboratories
  • Qiagen
  • Quest Diagnostics
  • Roche Diagnostics

Other Prominent Vendors

  • Biocartis
  • BioMerieux
  • Cepheid
  • EKF Diagnostics
  • Elitech
  • IntegraGen
  • Interpace Diagnostics
  • Luminex
  • Myriad Genetics
  • PerkinElmer
  • Seegene
  • WaferGen Biosystems

Market Driver

  • Rise in Number of Genetic Diseases
  • For a full, detailed list, view our report

Market Challenge

  • High Costs
  • For a full, detailed list, view our report

Market Trend

  • Growing Demand for Personalized Medicine
  • For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2019 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

08. Regulation of Genetic Testing

09. DTC Genetic Testing

    • 09.1.1. Advantages and Disadvantages of DTC Genetic Testing
    • 09.1.2. Regulation of DTC Genetic Testing

10. Geographical Segmentation

  • 10.1. Genetic Testing Market in Americas
    • 10.1.1. Market Size and Forecast
  • 10.2. Genetic Testing Market in EMEA
    • 10.2.1. Market Size and Forecast
  • 10.3. Genetic Testing Market in APAC
    • 10.3.1. Market Size and Forecast

11. Buying Criteria

12. Market Growth Drivers

13. Drivers and their Impact

14. Market Challenges

15. Impact of Drivers and Challenges

16. Market Trends

17. Trends and their Impact

18. Vendor Landscape

  • 18.1. Competitive Scenario
    • 18.1.1. Mergers and Acquisitions
  • 18.2. Market Share Analysis 2014
  • 18.3. Other Prominent Vendors

19. Key Vendor Analysis

  • 19.1. Abbott Laboratories
    • 19.1.1. Key Facts
    • 19.1.2. Business Description
    • 19.1.3. Business Segmentation
    • 19.1.4. Business Strategy
    • 19.1.5. Revenue by Business Segmentation
    • 19.1.6. Revenue Comparison 2011 and 2012
    • 19.1.7. Revenue by Geographical Segmentation
    • 19.1.8. Key Information
    • 19.1.9. SWOT Analysis
  • 19.2. Bio-Rad Laboratories
    • 19.2.1. Key Facts
    • 19.2.2. Business Description
    • 19.2.3. Business Segmentation
    • 19.2.4. Business Strategy
    • 19.2.5. Revenue by Business Segmentation
    • 19.2.6. Revenue Comparison 2011 and 2012
    • 19.2.7. Revenue by Geographical Segmentation
    • 19.2.8. Key Information
    • 19.2.9. SWOT Analysis
  • 19.3. Qiagen
    • 19.3.1. Key Facts
    • 19.3.2. Business Overview
    • 19.3.3. Product Segmentation by Revenue 2013
    • 19.3.4. Product Segmentation by Revenue 2012 and 2013
    • 19.3.5. Geographical Segmentation by Revenue 2013
    • 19.3.6. Business Strategy
    • 19.3.7. Recent Developments
    • 19.3.8. SWOT Analysis
  • 19.4. Quest Diagnostics
    • 19.4.1. Key Facts
    • 19.4.2. Business Overview
    • 19.4.3. Business Segmentation by Revenue 2013
    • 19.4.4. Business Segmentation by Revenue 2011-2013
    • 19.4.5. Geographical Segmentation by Revenue 2013
    • 19.4.6. Business Strategy
    • 19.4.7. Recent Developments
    • 19.4.8. SWOT Analysis
  • 19.5. Roche Diagnostics
    • 19.5.1. Key Facts
    • 19.5.2. Business Overview
    • 19.5.3. Business Segmentation by Revenue 2014
    • 19.5.4. Business Segmentation by Revenue 2013 and 2014
    • 19.5.5. Geographical Segmentation by Revenue 2014
    • 19.5.6. Business Strategy
    • 19.5.7. Recent Developments
    • 19.5.8. SWOT Analysis

20. Other Reports in this Series

List of Exhibits

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: Global Genetic Testing Market 2014-2019 ($ millions)
  • Exhibit 3: Evolution of Genetic Testing Segments
  • Exhibit 4: Segmentation of Global Genetic Testing Market by Application
  • Exhibit 5: Regulation of Genetic Testing in US
  • Exhibit 6: Global Genetic Testing Market by Geography 2014
  • Exhibit 7: Genetic Testing Market in Americas 2014-2019 ($ millions)
  • Exhibit 8: Genetic Testing Market in EMEA 2014-2019 ($ millions)
  • Exhibit 9: Genetic Testing Market in APAC 2014-2019 ($ millions)
  • Exhibit 10: Segmentation of Genetic Testing Market Segmentation by Geography ($ millions)
  • Exhibit 11: Segmentation of Genetic Testing Market Segmentation by Geography (%)
  • Exhibit 12: Abbott Laboratories: Key Takeaways
  • Exhibit 13: Bio-Rad Laboratories: Key Takeaways
  • Exhibit 14: Qiagen: Key Takeaways
  • Exhibit 15: Quest Diagnostics: Key Takeaways
  • Exhibit 16: Roche Diagnostics: Key Takeaways
  • Exhibit 17: Abbott Laboratories: Business Segmentation
  • Exhibit 18: Abbott Laboratories: Revenue by Business Segmentation 2012
  • Exhibit 19: Abbott Laboratories: Revenue by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 20: Abbott Laboratories: Revenue by Geographical Segmentation 2012
  • Exhibit 21: Bio-Rad Laboratories: Business Segmentation
  • Exhibit 22: Bio-Rad Laboratories: Revenue by Business Segmentation 2012
  • Exhibit 23: Bio-Rad Laboratories: Revenue Comparison by Business Segmentation 2011 and 2012 (US$ million)
  • Exhibit 24: Bio-Rad Laboratories: Revenue by Geographical Segmentation 2012
  • Exhibit 25: Qiagen: Product Segmentation by Revenue 2013
  • Exhibit 26: Qiagen: Product Segmentation by Revenue 2012 and 2013 (US$ million)
  • Exhibit 27: Qiagen: Geographical Segmentation by Revenue 2013
  • Exhibit 28: Global Genetic Testing Market: Business Segmentation by Revenue 2013
  • Exhibit 29: Global Genetic Testing Market: Business Segmentation by Revenue 2011-2013 (US$ billion)
  • Exhibit 30: Global Genetic Testing Market: Geographical Segmentation by Revenue 2013
  • Exhibit 31: Roche Diagnostics: Business Segmentation by Revenue 2014
  • Exhibit 32: Roche Diagnostics: Business Segmentation by Revenue 2013 and 2014 ($ billion)
  • Exhibit 33: Roche Diagnostics: Geographical Segmentation by Revenue 2014
Back to Top